Overview
AI-driven structure-based drug discovery using deep learning for binding prediction.
Details
Atomwise now operates as Numerion Labs, and atomwise.com redirects to numerionlabs.ai. The company uses a machine learning platform to search chemical space for drug-like small molecules and runs its own programs in immune and inflammatory diseases.